These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 202522)

  • 21. Augmentation of delayed-type hypersensitivity by vesicular stomatitis virus infection in mice.
    Katsura Y; Takaoki M; Kono Y; Minato N
    J Immunol; 1980 Oct; 125(4):1459-62. PubMed ID: 6157735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
    Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
    Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconstitution with T lymphocytes protects nude mice from a central nervous system disorder induced by a temperature-sensitive vesicular stomatitis virus.
    Doll SC; Johnson TC
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1969-77. PubMed ID: 2841409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of vesicular stomatitis virus major glycoprotein in determining the specificity of virus-specific and H-2-restricted cytolytic T cells.
    Sethi KK; Brandis H
    Eur J Immunol; 1980 Apr; 10(4):268-72. PubMed ID: 6249612
    [No Abstract]   [Full Text] [Related]  

  • 25. Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus.
    Hom RC; Soman G; Finberg R
    J Virol; 1989 Oct; 63(10):4157-64. PubMed ID: 2550662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimal molecular and cellular requirements for elicitation of secondary anti-vesicular stomatitis virus cytotoxic T lymphocytes.
    Hale AH; Ruebush MJ
    J Immunol; 1980 Oct; 125(4):1569-77. PubMed ID: 6251135
    [No Abstract]   [Full Text] [Related]  

  • 27. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.
    Hosken NA; Bevan MJ
    J Exp Med; 1992 Mar; 175(3):719-29. PubMed ID: 1311017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus.
    Thomsen AR; Nansen A; Andersen C; Johansen J; Marker O; Christensen JP
    Int Immunol; 1997 Nov; 9(11):1757-66. PubMed ID: 9418136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
    Forman J; Goodenow RS; Hood L; Ciavarra R
    J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes.
    Ruebush MJ; Hale AH; Lefrancois L; Harris DT; Burgess DE
    J Immunol; 1981 May; 126(5):2053-9. PubMed ID: 6260862
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex.
    Sakita I; Hörig H; Sun R; Wang F; Nathenson SG
    J Immunol Methods; 1996 Jun; 192(1-2):105-15. PubMed ID: 8699005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
    Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
    Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice.
    Charan S; Huegin AW; Cerny A; Hengartner H; Zinkernagel RM
    J Virol; 1986 Mar; 57(3):1139-44. PubMed ID: 3005615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation of delayed-type hypersensitivity to serum proteins by vesicular stomatitis virus infection in mice: virus-suppressor cell interactions.
    Katsura Y; Takaoki Y; Minato N
    J Immunol; 1982 Jul; 129(1):362-5. PubMed ID: 6177756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.
    Bründler MA; Aichele P; Bachmann M; Kitamura D; Rajewsky K; Zinkernagel RM
    Eur J Immunol; 1996 Sep; 26(9):2257-62. PubMed ID: 8814275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of cells of hematopoietic origin in genetically determined resistance of Syrian hamsters to vesicular stomatitis virus.
    Fultz PN; Shadduck JA; Kang CY; Streilein JW
    Infect Immun; 1981 Nov; 34(2):540-9. PubMed ID: 6273320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cell-independent B cell activation during acute virus infection: a role for early CCR7-driven B-T helper cell collaboration.
    Scandella E; Fink K; Junt T; Senn BM; Lattmann E; Förster R; Hengartner H; Ludewig B
    J Immunol; 2007 Feb; 178(3):1468-76. PubMed ID: 17237395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prostaglandins on elicitation of anti-viral-cytolytic activity.
    Hale AH; Evans DL; Daniel LW
    Immunol Lett; 1982 Mar; 4(3):171-4. PubMed ID: 6281179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.
    Bi Z; Barna M; Komatsu T; Reiss CS
    J Virol; 1995 Oct; 69(10):6466-72. PubMed ID: 7545248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
    Sheil JM; Bevan MJ; Lefrancois L
    J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.